Cleerly ISCHEMIA vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly ISCHEMIA specializes in analyzing CCTA scans to determine the likelihood of coronary artery ischemia and characterize plaque, focusing on coronary heart disease. In contrast, Us2.v2 automates the interpretation of echocardiograms to provide comprehensive reports and detect a broader range of cardiac conditions, including heart failure and valvular disease. The tools are adjacent in their shared goal of cardiac diagnosis but differ significantly in the imaging modality they analyze and their specific diagnostic outputs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Cleerly ISCHEMIA is designed to analyze CCTA (Coronary Computed Tomography Angiography) scans to provide insights into coronary artery disease. Us2.v2, on the other hand, specializes in automating the interpretation of echocardiograms, processing various cardiac ultrasound images.
Cleerly ISCHEMIA focuses on determining the likelihood of coronary artery ischemia at a vessel level, characterizing coronary plaque (volume, type, location), and assessing stenosis severity. Us2.v2 offers automated detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, delivering a complete structured echo report with measurements and clinical findings.
Cleerly ISCHEMIA integrates with PowerScribe via API, with data transfer facilitated by Cleerly Proxy using VPN or a virtual appliance. Us2.v2 offers seamless integration with existing PACS, CVIS, or EMR systems, supporting both HL7 and DICOM SR.
Cleerly ISCHEMIA provides comprehensive interactive web-based reports based on its CCTA analysis, aiding physicians in personalized diagnosis and treatment planning. Us2.v2 offers 100% AI automation, eliminating manual frame selection and annotation, which can reduce reporting time by up to 70% and increase daily scan throughput.
Cleerly ISCHEMIA's description focuses on its CCTA analysis capabilities and does not specify particular hardware compatibilities beyond requiring CCTA scans. Us2.v2 is explicitly compatible with any ultrasound manufacturer, including GE, Philips, Siemens, and handheld POCUS devices.
More Comparisons
Backers
Who funded each tool's parent company.